Global /South Korea /Healthcare /Drug Manufacturers - General /007570
chevron_leftBack
Ilyang Pharmaceutical Co.,Ltd logo

Ilyang Pharmaceutical Co.,Ltd

007570
KRX: 007570 Delayed
11,280KRW -1.5%
7.51 USD
As of 12 July 2026, Ilyang Pharmaceutical Co.,Ltd has a market cap of $136.28M USD, ranking #23444 globally and #954 in South Korea. It ranks #2103 in the Healthcare sector, and #760 in the Drug Manufacturers - General industry.
Global Rank
23444
1d: 0
1w: +148
1m: -
Country Rank
954
1d: 0
1w: +37
1m: -
Sector Rank
2103
1d: 0
1w: +14
1m: -
Industry Rank
760
1d: 0
1w: +5
1m: -
Key Stats
Market Cap
$136.28MUSD
205.24B KRW
Enterprise Value
$204.72MUSD
307.33B KRW
Revenue (TTM)
$180.89MUSD
272.42B KRW
EBITDA (TTM)
$8.86MUSD
13.31B KRW
Net Income (TTM)
$4.58MUSD
6.9B KRW
EBITDA Margin
4.9%
Profit Margin
2.5%
PE Ratio
30.5
PS Ratio
0.8
PB Ratio
0.9
EV/EBITDA
24.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Dong-Yeon Kim open_in_new
Employees
666
Founded
1946
Website
home.ilyang.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.5% -0.7% -12% -13% -13% -6.9%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
007570
일양약품(주)
ISIN: KR7007570005
Shares Out.:
17.925M1 Shares Float: 12.014M2
TV:
SA:
YF:
GF:
BA:
MS:
11,280 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Ilyang Pharmaceutical Co.,Ltd

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages. In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate, magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide, synthetic aluminum silicate, and other products. Ilyang Pharmaceutical Co.,Ltd also exports its products. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharmaceutical Co., Ltd. in May 1991. Ilyang Pharmaceutical Co.,Ltd was founded in 1946 and is headquartered in Yongin-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.24B
13.91T KRW
7K%
-
$5.29B
7.97T KRW
4K%
29.9
298380
$5.01B
7.55T KRW
4K%
-
000100
$4.6B
6.92T KRW
3K%
35.9
$4.49B
6.76T KRW
3K%
-
$4.07B
6.12T KRW
3K%
36.1
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
559K%
38.1
JNJ
$547.28B
401K%
26.4
ABBV
$360.63B
265K%
97.4
$317.7B
256.25B CHF
233K%
19.9
AZN
$289.23B
215.59B GBP
212K%
27.6
MRK
$274.03B
201K%
15.1
chevron_leftBack